Science Sun Pharmaceutical's Unit Completes License Amendment

MT NewswiresNov 21 12:17

Express News | Beijing Science Sun Pharmaceutical: The subsidiary's pharmaceutical production license change has been approved.

BreakingsNov 20 16:07

Saisheng Pharmaceutical: Report for the third quarter of 2024

SZSIOct 25 00:00 · Announcements

Beijing Science Sun Pharmaceutical (300485.SZ) released its performance for the first three quarters, with a net loss of 98.1982 million yuan.

Beijing Science Sun Pharmaceutical (300485.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 3...

Zhitong FinanceOct 24 20:39

Beijing Science Sun Pharmaceutical (300485.SZ): a net loss of 98.1982 million yuan in the first three quarters.

On October 24th, Gelonghui reported that Beijing Science Sun Pharmaceutical (300485.SZ) released the third quarter report of 2024. In the first three quarters of 2024, the company achieved revenue of 0.323 billion yuan, a decrease of 18.01% year-on-year; the net loss attributable to the shareholders of the listed company was 98.1982 million yuan, a decrease of 149.97% year-on-year; the net profit after deducting non-recurring gains and losses was 17.5475 million yuan, a decrease of 21.27% year-on-year; basic earnings per share was -0.20 yuan per share.

Gelonghui FinanceOct 24 17:51

Beijing Science Sun Pharmaceutical (300485.SZ): The company's related products have been approved for use in patients with acute ischemic stroke.

Beijing Science Sun Pharmaceutical (300485.SZ) announced that the company has followed the State Food and Drug Administration's "Regarding Single Psilocybin Tetrahexyloxide...

Zhitong FinanceOct 23 12:25